1. Home
  2. SLNO vs WK Comparison

SLNO vs WK Comparison

Compare SLNO & WK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • WK
  • Stock Information
  • Founded
  • SLNO 1999
  • WK 2008
  • Country
  • SLNO United States
  • WK United States
  • Employees
  • SLNO N/A
  • WK N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • WK Computer Software: Prepackaged Software
  • Sector
  • SLNO Health Care
  • WK Technology
  • Exchange
  • SLNO Nasdaq
  • WK Nasdaq
  • Market Cap
  • SLNO 3.8B
  • WK 3.7B
  • IPO Year
  • SLNO 2014
  • WK 2014
  • Fundamental
  • Price
  • SLNO $49.71
  • WK $79.16
  • Analyst Decision
  • SLNO Strong Buy
  • WK Strong Buy
  • Analyst Count
  • SLNO 10
  • WK 10
  • Target Price
  • SLNO $112.50
  • WK $103.00
  • AVG Volume (30 Days)
  • SLNO 1.7M
  • WK 734.4K
  • Earning Date
  • SLNO 11-05-2025
  • WK 11-05-2025
  • Dividend Yield
  • SLNO N/A
  • WK N/A
  • EPS Growth
  • SLNO N/A
  • WK N/A
  • EPS
  • SLNO N/A
  • WK N/A
  • Revenue
  • SLNO $32,656,999.00
  • WK $806,977,000.00
  • Revenue This Year
  • SLNO N/A
  • WK $21.48
  • Revenue Next Year
  • SLNO $175.39
  • WK $15.68
  • P/E Ratio
  • SLNO N/A
  • WK N/A
  • Revenue Growth
  • SLNO N/A
  • WK 19.02
  • 52 Week Low
  • SLNO $41.50
  • WK $60.50
  • 52 Week High
  • SLNO $90.32
  • WK $116.83
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 22.26
  • WK 54.42
  • Support Level
  • SLNO $50.63
  • WK $75.07
  • Resistance Level
  • SLNO $72.99
  • WK $81.67
  • Average True Range (ATR)
  • SLNO 4.32
  • WK 2.52
  • MACD
  • SLNO -1.60
  • WK -0.34
  • Stochastic Oscillator
  • SLNO 3.34
  • WK 53.89

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About WK Workiva Inc.

Workiva Inc is a cloud-native platform that simplifies the complexities of reporting and compliance. Workiva platform empowers customers by connecting and transforming data from hundreds of enterprise resource planning (ERP), human capital management (HCM), and customer relationship management (CRM) systems, as well as other third-party cloud and on-premise applications. Customers use the platform to create, review and publish data-linked documents and reports with greater control, consistency, accuracy, and productivity and it is also used for SEC Filings. Company's Geographical region consist of USA, Netherland, UK, and Others. Majority of revenue is from USA.

Share on Social Networks: